A novel CD7-directed antibody-drug conjugate targeting BCL-XL with potent anti-leukemic activity in T-cell acute lymphoblastic leukemia.

Oliveira ML, Nuantang K, Huré G, Ávila-Ávila A, Bresson L, Haumont S, Kostova V, Novak T, Le Toumelin-Braizat G, Guerlesquin J, Demarles D, Merdas M, Cauquil N, Goundiam O, Rocchetti F, Courtade-Gaiani S, Valour D, Zerhouni M, Artus R, Douillet-Michel E, Laurent I, Denis A, Ovreiu A, Duvauchelle B, Ecsedi M, Colland F, Geneste O, Maragno AL, Ghysdael J, Tran Quang C

Open source

DOI: 10.1038/s41375-026-02998-z
Published: 2026 Aug
Container: Leukemia
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41375-026-02998-z,
  title = {A novel CD7-directed antibody-drug conjugate targeting BCL-XL with potent anti-leukemic activity in T-cell acute lymphoblastic leukemia.},
  author = {Oliveira ML and Nuantang K and Huré G and Ávila-Ávila A and Bresson L and Haumont S and Kostova V and Novak T and Le Toumelin-Braizat G and Guerlesquin J and Demarles D and Merdas M and Cauquil N and Goundiam O and Rocchetti F and Courtade-Gaiani S and Valour D and Zerhouni M and Artus R and Douillet-Michel E and Laurent I and Denis A and Ovreiu A and Duvauchelle B and Ecsedi M and Colland F and Geneste O and Maragno AL and Ghysdael J and Tran Quang C},
  year = {2026},
  journal = {Leukemia},
  doi = {10.1038/s41375-026-02998-z},
  url = {https://doi.org/10.1038/s41375-026-02998-z}
}

RIS

TY  - JOUR
TI  - A novel CD7-directed antibody-drug conjugate targeting BCL-XL with potent anti-leukemic activity in T-cell acute lymphoblastic leukemia.
AU  - Oliveira ML
AU  - Nuantang K
AU  - Huré G
AU  - Ávila-Ávila A
AU  - Bresson L
AU  - Haumont S
AU  - Kostova V
AU  - Novak T
AU  - Le Toumelin-Braizat G
AU  - Guerlesquin J
AU  - Demarles D
AU  - Merdas M
AU  - Cauquil N
AU  - Goundiam O
AU  - Rocchetti F
AU  - Courtade-Gaiani S
AU  - Valour D
AU  - Zerhouni M
AU  - Artus R
AU  - Douillet-Michel E
AU  - Laurent I
AU  - Denis A
AU  - Ovreiu A
AU  - Duvauchelle B
AU  - Ecsedi M
AU  - Colland F
AU  - Geneste O
AU  - Maragno AL
AU  - Ghysdael J
AU  - Tran Quang C
PY  - 2026
JO  - Leukemia
DO  - 10.1038/s41375-026-02998-z
UR  - https://doi.org/10.1038/s41375-026-02998-z
ER  -

APA

ML, O., K, N., G, H., A, Á., L, B., S, H., V, K., T, N., G, L. T., J, G., D, D., M, M., N, C., O, G., F, R., S, C., D, V., M, Z., R, A., E, D., I, L., A, D., A, O., B, D., M, E., F, C., O, G., AL, M., J, G., & C, T. Q. (2026). A novel CD7-directed antibody-drug conjugate targeting BCL-XL with potent anti-leukemic activity in T-cell acute lymphoblastic leukemia.. Leukemia. https://doi.org/10.1038/s41375-026-02998-z

Source records

pubmed · retrieved 2026-09-26T01:34:33.525Z
europe-pmc · retrieved 2026-09-26T01:34:33.545Z